Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT05673590 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

612

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Interventions

DRUG: Utidelone Injection
DRUG: Docetaxel Injection

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.